January 8, 2008 — JPK Instruments AG, a Berlin-based company that develops nanotech measuring and analytical instruments, has increased its share in JPK subsidiary nAmbition GmbH in Dresden to 100 percent, extending its product portfolio and significantly boosting its Molecular Analytics division, the company said in a news release.

The company said it is now positioned in the rapidly growing market for instruments and techniques used in nanobiotechnology and molecular biology.

For example, ForceRobot, a product developed by the Dresden-based company and launched in 2007, is the first product of its kind that enables automated measurements on individual molecules, producing a protein fingerprint, the company said.

Among other applications, this feature can be used to identify where active ingredients in drugs bind to the target molecule, as well as the strength of the resultant binding, making it possible to gain targeted insights into the complex interactions of individual bio-molecules with active ingredients.

“The complete takeover of nAmbition now provides us with an opportunity to exploit major synergy potential. We will integrate nAmbition into our overall marketing and sales structure and further boost its sales and earnings contributions,” said Frank Pelzer, CEO of JPK Instruments AG.